ShRNA-mediated decreases in c-met levels affect the differentiation potential of human mesenchymal stem cells and reduce their capacity for tissue repair

Tissue Engineering - Part A

Volumn 16, Issue 8, 2010, Pages 2627-2639

  Rosová, Ivana ^a   Link, Daniel ^a   Nolta, Jan A ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD; CELL CULTURE; HEMODYNAMICS; RESTORATION; SIGNALING;

ADIPOGENIC; BLOOD FLOW; CHONDROGENIC; HEPATOCYTE GROWTH FACTOR; HIND LIMBS; HUMAN MESENCHYMAL STEM CELLS; HYPOXIC CONDITION; HYPOXIC ENVIRONMENTS; IN-VITRO; INJURY MODELS; INTERMEDIATE CAPACITY; ISCHEMIC INJURIES; ISCHEMIC LIMBS; MULTIPOTENT CELLS; NORMOXIC CONDITIONS; OSTEOGENIC; SIGNALING PATHWAYS; STROMAL CELLS; TISSUE REPAIR; UP-REGULATION;

STEM CELLS;

SCATTER FACTOR RECEPTOR; SMALL INTERFERING RNA;

ANIMAL; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CULTURE TECHNIQUE; CYTOLOGY; FEASIBILITY STUDY; GENETIC ENHANCEMENT; GENETICS; HINDLIMB; HUMAN; ISCHEMIA; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; METABOLISM; METHODOLOGY; MOUSE; MOUSE MUTANT; PHYSIOLOGY; REGENERATION; TREATMENT OUTCOME; UPREGULATION; VASCULARIZATION;

ANIMALS; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELLS, CULTURED; FEASIBILITY STUDIES; GENETIC ENHANCEMENT; HINDLIMB; HUMANS; ISCHEMIA; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MICE; MICE, SCID; PROTO-ONCOGENE PROTEINS C-MET; REGENERATION; RNA, SMALL INTERFERING; TREATMENT OUTCOME; UP-REGULATION;

EID: 77956072110     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2009.0363     Document Type: Article

References (63)

1. Horwitz, E.M., Le Blanc, K., Dominici, M., Mueller, I., Slaper-Cortenbach, I., Marini, F.C., Deans, R.J., Krause, D.S., and Keating, A. Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Cytotherapy 7, 393, 2005.
2. Pittenger, M.F., Mackay, A.M., Beck, S.C., Jaiswal, R.K., Douglas, R., Mosca, J.D., Moorman, M.A., Simonetti, D.W., Craig, S., and Marshak, D.R. Multilineage potential of adult human mesenchymal stem cells. Science 284, 143, 1999.
3. Makino, S., Fukuda, K., Miyoshi, S., Konishi, F., Kodama, H., Pan, J., Sano, M., Takahashi, T., Hori, S., Abe, H., Hata, J., Umezawa, A., and Ogawa, S. Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest 103, 697, 1999.
4. Sanchez-Ramos, J., Song, S., Cardozo-Pelaez, F., Hazzi, C., Stedeford, T., Willing, A., Freeman, T.B., Saporta, S., Janssen, W., Patel, N., Cooper, D.R., and Sanberg, P.R. Adult bone marrow stromal cells differentiate into neural cells in vitro. Exp Neurol 164, 247, 2000.
5. Rosova, I., Dao, M., Capoccia, B., Link, D., and Nolta, J.A. Hypoxic preconditioning results in increased motility and improved therapeutic potential of human mesenchymal stem cells. Stem Cells 26, 2173, 2008.
6. Laflamme, M.A., and Murry, C.E. Regenerating the heart. Nat Biotechnol 23, 845, 2005.
7. Kinnaird, T., Stabile, E., Burnett, M.S., Lee, C.W., Barr, S., Fuchs, S., and Epstein, S.E. Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ Res 94, 678, 2004.
8. Sato, T., Fujieda, H., Murao, S., Sato, H., Takeuchi, T., and Ohtsuki, Y. Sequential changes of hepatocyte growth factor in the serum and enhanced c-Met expression in the myocardium in acute myocardial infarction. Jpn Circ J 63, 906, 1999.
9. Nakamura, T., Nawa, K., and Ichihara, A. Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem Biophys Res Commun 122, 1450, 1984.
10. Maroun, C.R., Naujokas, M.A., Holgado-Madruga, M., Wong, A.J., and Park, M. The tyrosine phosphatase SHP-2 is required for sustained activation of extracellular signal-regulated kinase and epithelial morphogenesis downstream from the met receptor tyrosine kinase. Mol Cell Biol 20, 8513, 2000.
11. Ware, L.B., and Matthay, M.A. Keratinocyte and hepatocyte growth factors in the lung: roles in lung development, inflammation, and repair. Am J Physiol Lung Cell Mol Physiol 282, L924, 2002.
12. Neuss, S., Becher, E., Woltje, M., Tietze, L., and Jahnen-Dechent, W. Functional expression of HGF and HGF receptor/c-met in adult human mesenchymal stem cells suggests a role in cell mobilization, tissue repair, and wound healing. Stem Cells 22, 405, 2004.
13. Forte, G., Minieri, M., Cossa, P., Antenucci, D., Sala, M., Gnocchi, V., Fiaccavento, R., Carotenuto, F., De Vito, P., Baldini, P.M., Prat, M., and Di Nardo, P. Hepatocyte growth factor effects on mesenchymal stem cells: proliferation, migration, and differentiation. Stem Cells 24, 23, 2006.
14. Nakamura, T., Nishizawa, T., Hagiya, M., Seki, T., Shimo-nishi, M., Sugimura, A., Tashiro, K., and Shimizu, S. Molecular cloning and expression of human hepatocyte growth factor. Nature 342, 440, 1989.
15. Sonnenberg, E., Meyer, D., Weidner, K.M., and Birchmeier, C. Scatter factor/hepatocyte growth factor and its receptor, the c-met tyrosine kinase, can mediate a signal exchange between mesenchyme and epithelia during mouse development. J Cell Biol 123, 223, 1993.
16. Noji, S., Tashiro, K., Koyama, E., Nohno, T., Ohyama, K., Taniguchi, S., and Nakamura, T. Expression of hepatocyte growth factor gene in endothelial and Kupffer cells of damaged rat livers, as revealed by in situ hybridization. Biochem Biophys Res Commun 173, 42, 1990.
17. Fujimoto, J. Gene therapy for liver cirrhosis. J Gastroenterol Hepatol 15 Suppl, D33, 2000.
18. Yasuda, S., Goto, Y., Baba, T., Satoh, T., Sumida, H., Miya-zaki, S., and Nonogi, H. Enhanced secretion of cardiac he-patocyte growth factor from an infarct region is associated with less severe ventricular enlargement and improved cardiac function. J Am Coll Cardiol 36, 115, 2000.
19. Sato, T., Fujieda, H., Murao, S., Sato, H., Takeuchi, T., and Ohtsuki,Y.Sequential changes of hepatocyte growth factor in the serum and enhanced c-Met expression inthe myocardium in acute myocardial infarction. Jpn Circ J 63, 906, 1999.
20. Sheehan, S.M., Tatsumi, R., Temm-Grove, C.J., and Allen, R.E. HGF is an autocrine growth factor for skeletal muscle satellite cells in vitro. Muscle Nerve 23, 239, 2000.
21. Mizuno, K., Higuchi, O., Ihle, J.N., and Nakamura, T. Hepatocyte growth factor stimulates growth of hematopoi-etic progenitor cells. Biochem Biophys Res Commun 194, 178, 1993.
22. Galimi, F., Bagnara, G.P., Bonsi, L., Cottone, E., Follenzi, A., Simeone, A., and Comoglio, P.M. Hepatocyte growth factor induces proliferation and differentiation of multipotent and erythroid hemopoietic progenitors. J Cell Biol 127, 1743, 1994.
23. Nishino, T., Hisha, H., Nishino, N., Adachi, M., and Ikehara, S. Hepatocyte growth factor as a hematopoietic regulator. Blood 85, 3093, 1995.
24. Ikehara, S. Role of hepatocyte growth factor in hemopoiesis. Leuk Lymphoma 23, 297, 1996.
25. Ratajczak, M.Z., Marlicz, W., Ratajczak, J., Wasik, M., Machalinski, B., Carter, A., and Gewirtz, A.M. Effect of hepatocyte growth factor on early human haemopoietic cell development. Br J Haematol 99, 228, 1997.
26. Yu, C.Z., Hisha, H., Li, Y., Lian, Z., Nishino, T., Toki, J., Adachi, Y., Inaba, M., Fan, T.X., Jin, T., Iguchi, T., Sogo, S., Hosaka, N., Song, T.H., Xing, J., and Ikehara, S. Stimulatory effects of hepatocyte growth factor on hemopoiesis of SCF/c-kit system-deficient mice. Stem Cells 16, 66, 1998.
27. \+ cells. Stem Cells 17, 82, 1999.
28. \+). Exp Hematol 26, 885, 1998.
29. \+ progenitor cells are the result of c-met receptor expression. Stem Cells 14, 592, 1996.
30. D'Ippolito, G., Schiller, P.C., Perez-stable, C., Balkan, W., Roos, B.A., and Howard, G.A. Cooperative actions of he-patocyte growth factor and 1,25-dihydroxyvitamin D3 in osteoblastic differentiation of human vertebral bone marrow stromal cells. Bone 31, 269, 2002.
31. Duan, H.F., Wu, C.T., Wu, D.L., Lu, Y., Liu, H.J., Ha, X.Q., Zhang, Q.W., Wang, H., Jia, X.X., and Wang, L.S. Treatment of myocardial ischemia with bone marrow-derived mesen-chymal stem cells overexpressing hepatocyte growth factor. Mol Ther 8, 467, 2003.
32. Cai, L., Johnstone, B.H., Cook, T.G., Liang, Z., Traktuev, D., Cornetta, K., Ingram, D.A., Rosen, E.D., and March, K.L. Suppression of hepatocyte growth factor production impairs the ability of adipose-derived stem cells to promote ischemic tissue revascularization. Stem Cells 25, 3234, 2007.
33. Damert, A., Ikeda, E., and Risau, W. Activator-protein-1 binding potentiates the hypoxia-induciblefactor-1-mediated hypoxia-induced transcriptional activation of vascular-endothelial growth factor expression in C6 glioma cells. Biochem J 327 (Pt 2), 419, 1997.
34. Loike, J.D., Cao, L., Brett, J., Ogawa, S., Silverstein, S.C., and Stern, D. Hypoxia induces glucose transporter expression in endothelial cells. Am J Physiol 263, C326, 1992.
35. Hu, X., Yu, S.P., Fraser, J.L., Lu, Z., Ogle, M.E., Wang, J.A., and Wei, L. Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis. J Thorac Cardiovasc Surg 135, 799, 2008.
36. Liu, X.B., Jiang, J., Gui, C., Hu, X.Y., Xiang, M.X., and Wang, J.A. Angiopoietin-1 protects mesenchymal stem cells against serum deprivation and hypoxia-induced apoptosis through the PI3K/Akt pathway. Acta Pharmacol Sin 29, 815, 2008.
37. Won Kim, H., Haider, H.K., Jiang, S., and Ashraf, M. Ischemic preconditioning augments survival of stem cells via miR-210 expression by targeting caspase-8-associated protein 2. J Biol Chem 284, 33161, 2009.
38. Li, N., Hill, K.S., and Elferink, L.A. Analysis of receptor ty-rosine kinase internalization using flow cytometry. Methods Mol Biol (Clifton, NJ) 457, 305, 2008.
39. Naka, D., Shimomura, T., Yoshiyama, Y., Sato, M., Sato, M., Ishii, T., and Hara, H. Internalization and degradation of hepatocyte growth factor in hepatocytes with down-regulation of the receptor/c-Met. FEBS Lett 329, 147, 1993.
40. Pennacchietti, S., Michieli, P., Galluzzo, M., Mazzone, M., Giordano, S., and Comoglio, P.M. Hypoxia promotes invasive growth by transcriptional activation of the met proto-oncogene. Cancer Cell 3, 347, 2003.
41. Dao, M.A., Pepper, K.A., and Nolta, J.A. Long-term cytokine production from engineered primary human stromal cells influences human hematopoiesis in an in vivo xenograft model. Stem Cells 15, 443, 1997.
42. Nolta, J.A., Hanley, M.B., and Kohn, D.B. Sustained human hematopoiesis in immunodeficient mice by cotransplantation of marrow stroma expressing human interleukin-3: analysis of gene transduction of long-lived progenitors. Blood 83, 3041, 1994.
43. Meyerrose, T., Rosova, I., Dao, M., Herrbrich, P., Bauer, G., and Nolta, J. Establishment and Transduction of Primary Human Sromal/Mesenchymal Stem Cell Monolayers. Dordrecht, The Netherlands: Kluwer Academic Publishers, 2006.
44. Dao, M.A., and Nolta, J.A. Cytokine and integrin stimulation synergize to promote higher levels of GATA-2, c-myb, and CD34 protein in primary human hematopoietic progenitors from bone marrow. Blood 109, 2373, 2007.
45. Rich, J.T., Rosova, I., Nolta, J.A., Myckatyn, T.M., Sandell, L.J., and McAlinden, A. Upregulation of Runx2 and Osterix during in vitro chondrogenesis of human adipose-derived stromal cells. Biochem Biophys Res Commun 372, 230, 2008.
46. Capoccia, B.J., Robson, D.L., Levac, K.D., Maxwell, D.J., Hohm, S.A., Neelamkavil, M.J., Bell, G.I., Xenocostas, A., Link, D.C., Piwnica-Worms, D., Nolta, J.A., and Hess, D.A. Revascularization of ischemic limbs after transplantation of human bone marrow cells with high aldehyde dehydroge-nase activity. Blood 113, 5340, 2009.
47. Zhou, P., Hohm, S., Capoccia, B., Wirthlin, L., Hess, D., Link, D., and Nolta, J. Immunodeficient mouse models to study human stem cell-mediated tissue repair. Methods Mol Biol 430, 213, 2008.
48. Digirolamo, C.M., Stokes, D., Colter, D., Phinney, D.G., Class, R., and Prockop, D.J. Propagation and senescence of human marrow stromal cells in culture: a simple colony-forming assay identifies samples with the greatest potential to propagate and differentiate. Br J Haematol 107, 275, 1999.
49. \+ cells. Blood 106, 1259, 2005.
50. Rosova, I., Dao, M., Capoccia, B., Link, D., and Nolta, J.A. Hypoxic preconditioning results in increased motility and improved therapeutic potential of human mesenchymal stem cells. Stem Cells 8, 2173, 2008.
51. Attwell, S., Roskelley, C., and Dedhar, S. The integrin-linked kinase (ILK) suppresses anoikis. Oncogene 19, 3811, 2000.
52. Gnecchi, M., He, H., Liang, O.D., Melo, L.G., Morello, F., Mu, H., Noiseux, N., Zhang, L., Pratt, R.E., Ingwall, J.S., and Dzau, V.J. Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat Med 11, 367, 2005.
53. Friedenstein, A.J., Chailakhjan, R.K., and Lalykina, K.S. The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet 3, 393, 1970.
54. Friedenstein, A.J., Chailakhyan, R.K., Latsinik, N.V., Pana-syuk, A.F., and Keiliss-Borok, I.V. Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues. Cloning in vitro and retransplantation in vivo. Transplantation 17, 331, 1974.
55. Bianco, P., and Gehron Robey, P. Marrow stromal stem cells. J Clin Invest 105, 1663, 2000.
56. Sacchetti, B., Funari, A., Michienzi, S., Di Cesare, S., Pier-santi, S., Saggio, I., Tagliafico, E., Ferrari, S., Robey, P.G., Riminucci, M., and Bianco, P. Self-renewing osteoprogeni-tors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell 131, 324, 2007.
57. Ng, F., Boucher, S., Koh, S., Sastry, K.S., Chase, L., Laksh-mipathy, U., Choong, C., Yang, Z., Vemuri, M.C., Rao, M.S., and Tanavde, V. PDGF, TGF-beta, and FGF signaling is important for differentiation and growth of mesenchymal stem cells (MSCs): transcriptional profiling can identify markers and signaling pathways important in differentiation of MSCs into adipogenic, chondrogenic, and osteogenic lineages. Blood 112, 295, 2008.
58. Watson, P., Lazowski, D., Han, V., Fraher, L., Steer, B., and Hodsman, A. Parathyroid hormone restores bone mass and enhances osteoblast insulin-like growth factor I gene expression in ovariectomized rats. Bone 16, 357, 1995.
59. Nakagami, H., Maeda, K., Morishita, R., Iguchi, S., Nishi-kawa, T., Takami, Y., Kikuchi, Y., Saito, Y., Tamai, K., Ogi-hara, T., and Kaneda, Y. Novel autologous cell therapy in ischemic limb disease through growth factor secretion by cultured adipose tissue-derived stromal cells. Arterioscler Thromb Vasc Biol 25, 2542, 2005.
60. Kim, S.W., Han, H., Chae, G.T., Lee, S.H., Bo, S., Yoon, J.H., Lee, Y.S., Lee, K.S., Park, H.K., and Kang, K.S. Successful stem cell therapy using umbilical cord blood-derived mul-tipotent stem cells for Buerger's disease and ischemic limb disease animal model. Stem Cells 24, 1620, 2006.
61. Morishita, R., Aoki, M., Hashiya, N., Makino, H., Yamasaki, K., Azuma, J., Sawa, Y., Matsuda, H., Kaneda, Y., and Ogi-hara, T. Safety evaluation of clinical gene therapy using hepatocyte growth factor to treat peripheral arterial disease. Hypertension 44, 203, 2004.
62. Morishita, R., Nakamura, S., Hayashi, S., Taniyama, Y., Moriguchi, A., Nagano, T., Taiji, M., Noguchi, H., Takeshita, S., Matsumoto, K., Nakamura, T., Higaki, J., and Ogihara, T. Therapeutic angiogenesis induced by human recombinant hepatocyte growth factor in rabbit hind limb ischemia model as cytokine supplement therapy. Hypertension 33, 1379, 1999.
63. Hayashi, S., Morishita, R., Nakamura, S., Yamamoto, K., Moriguchi, A., Nagano, T., Taiji, M., Noguchi, H., Matsumoto, K., Nakamura, T., Higaki, J., and Ogihara, T. Potential role of hepatocyte growth factor, a novel angiogenic growth factor, in peripheral arterial disease: downregulation of HGF in response tohypoxia in vascular cells. Circulation 100, II301, 1999.